This site is intended for health professionals only

Published on 8 December 2011

Share this story:
Twitter
LinkedIn

Interferon-b: first-line therapy in multiple sclerosis

teaser

Per Soelberg Sorensen

Danish Multiple Sclerosis Centre,

University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Approximately 85% of patients with multiple sclerosis (MS) have a relapsing



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn